Beyond EZH2: is the polycomb protein CBX2 an emerging target for anti-cancer therapy?
Jangal, Maïka, Lebeau, Benjamin, Witcher, MichaelLanguage:
english
Journal:
Expert Opinion on Therapeutic Targets
DOI:
10.1080/14728222.2019.1627329
Date:
June, 2019
File:
PDF, 1.73 MB
english, 2019